EU lists rare nerve disorder as side-effect of J&J COVID-19 vaccine

Published: Updated:
Enable Read mode
100% Font Size

Europe’s medicines regulator said on Thursday it had added a rare nerve-degenerating disorder, Guillain-Barré syndrome, as a possible rare side effect from Johnson & Johnson’s COVID-19 vaccine after it reviewed 108 cases reported worldwide.

For the latest headlines, follow our Google News channel online or via the app.


“After assessing the available data, PRAC considered that a causal relationship between COVID-19 vaccine Janssen and GBS is possible,” the European Medicines Agency said, referring to its safety committee, PRAC.

Read more:

Barclays raises this year’s oil price forecast by $3-5 per barrel

Israel to reimpose COVID-19 ‘Green Pass’ as Delta variant hits

US to impose sanctions on Cuban officials over crackdown on protests

Top Content Trending